| P/E (FY) | — | Sales (TTM) | $322.0M |
| Earnings (TTM) | -$102.5M | ROE | −24.89% |
| Net Margin | −31.02% | ROIC | −65.39% |
| Debt / Equity | 0.14 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 60.14% |
PROCEPT BioRobotics is a surgical robotics company developing solutions in urology in the United States and internationally. It develops, manufactures, and sells the AquaBeam Robotic System, an image-guided surgical robotic platform for minimally invasive urologic surgery focused on benign prostatic hyperplasia. The company also offers the HYDROS Robotic System, which delivers Aquablation therapy to treat men with lower urinary tract symptoms due to benign prostatic hyperplasia.
| Market Cap | $1.03B | Trading Days | 1217 |
| 52W High | 56.87 |
| 52W Low | 16.66 |
| % Off High | −68.21% |
| YTD | −42.53% | 1Y | −66.57% |
| 3Y | −48.77% | Since incept. (ann.) | −13.16% |
US 88% · Non Us 12%
| Ann. Volatility (1Y) | 64.01% | Ann. Volatility (3Y) | 60.73% |
| Sharpe (1Y) | −1.42 | Sharpe (3Y) | −0.08 |
| Max Drawdown (1Y) | −69.14% | Max Drawdown (3Y) | −83.22% |
| Beta (3Y, vs SPY) | 1.46 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| BVS | Bioventus Inc. | $910.4M | 40.0 |
| IRMD | IRADIMED CORP | $1.21B | 54.2 |
| TNDM | TANDEM DIABETES CARE INC | $1.22B | — |
| AORT | ARTIVION, INC. | $1.31B | 128.6 |
| SIBN | SI-BONE, Inc. | $795.2M | — |
| SSII | SS Innovations International, Inc. | $786.5M | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.40B | — |
| ATEC | Alphatec Holdings, Inc. | $1.41B | — |
| INSP | Inspire Medical Systems, Inc. | $1.50B | 10.6 |
| BBNX | Beta Bionics, Inc. | $704.1M | — |
| SGP | SpyGlass Pharma, Inc. | $696.1M | — |
| INTEGRA LIFESCIENCES HOLDINGS CORP |
| $1.54B |
| — |
